University Hospitals Case Medical Center

Surgery potentially best option for severe migraine headaches

CLEVELAND -- The disability from migraine headaches is an enormous health burden affecting over 30 million Americans.

African American lung cancer patients may have different response to new cancer-fighting drugs

Clinical research out of University Hospitals Case Medical Center has found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which may impact response to new cancer-fighting drugs.

University Hospitals Case Medical Center to test gammaglobulin treatment for Alzheimer's disease

Researchers from the Memory and Cognition Center at University Hospitals Case Medical Center will begin testing an intriguing new approach to slowing down the progression of Alzheimer's Disease (AD) using Intravenous Immune Globulin (IGIV), also known as gammaglobulin.

Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding

OAK BROOK, Ill. -- August 17, 2009 -- A new study shows that elderly patients who underwent endoscopy within one day of presentation for peptic ulcer bleeding had a two-day shorter hospital stay and were less likely to require upper gastrointestinal surgery than patients who did not receive endoscopy within the first day of presentation.

Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer

CLEVELAND -- A study published in this week's online issue of Nature Biotechnology, demonstrates a unique and highly sensitive method for detecting methylation-associated cancers.

Got migraines?

ARLINGTON HEIGHTS, Ill. -- Migraine headaches are a drain -- not only on the estimated 30 million Americans who suffer from them, but on the economy, too. Because pain and other symptoms caused by migraine headaches can be quite severe, it is projected that nearly $13 billion is spent every year in headache treatment and loss of time from work, which no one can afford these days.

Researchers identify individuals at risk for developing colon cancer

A new study identifies a group of individuals at increased risk for developing colon cancer and holds the promise for developing new tailored cancer treatments.

Researchers make discovery in colon cancer prevention

CLEVELAND ? A new study finds that individuals who have low expression of the "Celebrex gene," 15-PGDH, are actually resistant to Celebrex treatment when used to prevent colon cancer.